• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

LCA Joins Efforts to Protect Patient Access to Treatments

Article

The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare.

The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare. They Six Protected Classes at stake include therapies for epilepsy, mental illness, cancer, HIV, and organ transplants.

The ads will be featured in The Washington Post, The New york Times, The Hill, Roll Call, and Politico. Read the full press release.

Related Videos
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Kimberly Westrich, MA
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.